GFORCE-PD still going strong in 2016

Forskningsoutput: TidskriftsbidragÖversiktsartikel

Abstract

In 2014, a new initiative was undertaken by groups working on plans for the transplantation of stem-cell-based derived dopaminergic neurons for treating Parkinson’s disease patients. This GForce-PD group held its annual meeting on 18–19 April 2016 in Chicago at Rush University to discuss their progress and the challenges that the translation of this experimental therapy still faces. Over 2 days, the key issues were discussed around the cell lines that will be used, the differentiation protocols, preclinical testing, GMP-adaptation, and cell manufacturing to allow first in human clinical trials, which are anticipated to start in 2017–2018. GForce-PD members also discussed how they can improve outreach and be of better service to the Parkinson's disease (PD) community and help them to make the best possible decisions when pursuing stem cell treatments.

Detaljer

Författare
Enheter & grupper
Externa organisationer
  • John van Geest Centre for Brain Repair, University of Cambridge
  • Kyoto University
  • Memorial Sloan-Kettering Cancer Center
  • University of Cambridge
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Neurovetenskaper
  • Cell- och molekylärbiologi
Originalspråkengelska
Artikelnummer16014
TidskriftNPJ Parkinson's Disease
Volym3
StatusPublished - 2017 feb 23
PublikationskategoriForskning
Peer review utfördJa